Gilead has partnered with six generic manufacturers to expand access to HIV Drug lenacapavir in high-incidence, resource-limited countries following promising clinical trial results.

Gilead Sciences has achieved success with its HIV treatment drugs, including tenofovir disoproxil fumarate, but faces criticism for pricing and access issues. Learn about the controversy and ...